Morgan Stanley Remains Sidelined on Lamb Weston (LW) Following 1Q Results

Morgan Stanley reiterated an Equalweight rating and $50.00 price target on Lamb Weston (NYSE: LW) following the company's 1Q earnings report. LW once again exceeded EPS expectations with $0.57 vs. consensus estimates of $0.49, reinforcing what has become a common trend for the company since it's spin-off.

Despite Q1 upside, management reaffirmed its initial full year guidance, which calls for L-MSD sales growth and $740-760 Mn in EBITDA. The year is still expected to be back-half weighted largely due to incremental manufacturing capacity and the timing of customer contract renewals.

For an analyst ratings summary and ratings history on Lamb Weston click here. For more ratings news on Lamb Weston click here.

Shares of Lamb Weston closed at $48.41 yesterday.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
• Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink